Clinical Research Directory
Browse clinical research sites, groups, and studies.
Remimazolam on the Incidence of Postoperative Acute Kidney Injury
Sponsor: Seoul National University Bundang Hospital
Summary
We hypothesized that in patients undergoing elective hepatobiliary-pancreatic surgery, the group in which anesthesia is induced and maintained with remimazolam during surgery would maintain hemodynamic stability and reduce the incidence of postoperative acute kidney injury compared to propofol. The purpose is to provide practical evidence for perioperative management differentiated from other surgeries for hepatobiliary-pancreatic surgery patients for whom intraoperative fluid therapy is restricted.
Official title: The Effect of Intraoperative Remimazolam Administration on the Incidence of Postoperative Acute Kidney Injury After Hepatobiliary and Pancreatic Surgery : a Prospective Randomized Controlled Trial
Key Details
Gender
All
Age Range
19 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
78
Start Date
2026-06-26
Completion Date
2028-06-26
Last Updated
2026-06-29
Healthy Volunteers
No
Conditions
Interventions
Remimazolam (Byfavo)
TCI of remimazolam (0.3 - 1.5 mcg/ml)
propofol
TCI of propofol (4.0 - 5.0 mg/mL)
Locations (1)
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea